Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
- Beijing Children'S Hospital, Capital Medical University
Beijing, China
- Beijing Tongren Hospital, Capital Medical University
Beijing, China
- People'S Hospital of Peking University
Beijing, China
- Children'S Hospital of Hunan Province
Changsha, China
- the Second Xiangya Hospital of Central South University
Changsha, China
- Affiliated Hospital of Chengde Medical College
Chengde, China
- Sichuan Provincial People'S Hospital
Chengdu, China
- the Second People'S Hospital of Chengdu
Chengdu, China
- Affiliated Hospital of Chongqing Three Gorges Medical College
Chongqing, China
- the Second Affiliated Hospital of Chongqing Medical University
Chongqing, China
- the Sixth People'S Hospital of Dongguan
Dongguan, China
- Enshi Tujia and Miao Autonomous Prefecture Central Hospital
Enshi, China
- Dermatology Hospital of Southern Medical University
Guangzhou, China
- Hainan Fifth People'S Hospital
Haikou, China
- the First People'S Hospital of Hangzhou
Hangzhou, China
- Zhejiang Provincial People'S Hospital
Hangzhou, China
- the Second Affiliated Hospital of Harbin Medical University
Harbin, China
- Ji'Nan Central Hospital
Ji'nan, China
- the First Hospital of Jilin University
Jilin City, China
- the Fourth Affiliated Hospital of Zhejiang University School of Medicine
Jinhua, China
- the Second Affiliated Hospital of Henan University of Science and Technology
Luoyang, China
- Affiliated Hospital of Nantong University
Nantong, China
- Sanmenxia Central Hospital
Sanmenxia, China
- Shanghai Skin Disease Hospital
Shanghai, China
- the Second Affiliated Hospital of South Anhui Medical College
Wuhu, China
- the First Affiliated Hospital of Xi'An Jiaotong University
Xi'an, China
- the Second Affiliated Hospital of Xi'An Jiaotong University
Xi'an, China
- the First People'S Hospital of Yancheng
Yancheng, China
- Zhengzhou Central Hospital
Zhengzhou, China
- Affiliated Hospital of Jiangsu University
Zhenjiang, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Nov 2024
- Primary completion
- 13 Oct 2025
- Completion
- 15 Oct 2025
- Last update posted
- 6 Jul 2026
- Registered enrollment
- 190
- Registry id
- NCT06648772
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.